about
Impact of miR-21, miR-126 and miR-221 as prognostic factors of clear cell renal cell carcinoma with tumor thrombus of the inferior vena cava.MiR-205 is progressively down-regulated in lymph node metastasis but fails as a prognostic biomarker in high-risk prostate cancer.Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapyPreoperative C-Reactive Protein Values as a Potential Component in Outcome Prediction Models of Metastasized Renal Cell Carcinoma Patients Receiving Cytoreductive Nephrectomy.Metformin-Derived Growth Inhibition in Renal Cell Carcinoma Depends on miR-21-Mediated PTEN Expression.Maintenance monotherapy with Gemcitabine following cisplatin-based primary combination chemotherapy in surgically treated advanced urothelial carcinoma: A matched-pair single institution analysis.Survival in patients with high-risk prostate cancer is predicted by miR-221, which regulates proliferation, apoptosis, and invasion of prostate cancer cells by inhibiting IRF2 and SOCS3.68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CTMucin-Poor Mucinous Tubular and Spindle Cell Carcinoma of the Kidney Presented with Multiple Metastases Two Years after Nephrectomy: An Atypical Behaviour of a Rare, Indolent Tumour.Diagnosis and Clinical Management of Ruptured Ileocecal Pouches for Continent Cutaneous Urinary Diversion.[How should hormone therapy for castration-resistant prostate cancer be continued?]Long-Term Outcome of Nephron-Sparing Surgery Compared to Radical Nephrectomy for Renal Cell Carcinoma ≥4 cm - A Matched-Pair Single Institution Analysis
P50
Q34287632-28DACFF3-D6B7-4EAF-9E4C-54F738173475Q34381328-B6D40B66-91A6-41F1-B536-2411F47E1DD6Q37214430-CCE0DA0B-2B03-4A10-A803-62F558EFFC4CQ38720864-6D733EB3-1AA0-4089-87E6-B9D1EE661F52Q38825551-A363BE9F-14A5-4A1E-BB83-95AE6DC666A8Q38881827-F9D872D0-01E6-4103-889D-2FB71BCFC2E7Q39017421-F3E3F0C2-EC53-4DE9-9B56-B02F059D2FEFQ39922053-DA3BA5E3-22BE-422A-8427-A6AE2C6EC19DQ48213930-8DD78D42-78F1-4FE0-A8EE-DF52BFE7A846Q51117138-13F057B2-CC52-4A4F-A39B-EB0497AD62F7Q57135372-D730FE92-E2D9-4078-A366-BC1737F68EBFQ88088654-310340F6-14B0-4AF2-91D9-047ABA431B00
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Markus Krebs
@ast
Markus Krebs
@en
Markus Krebs
@es
Markus Krebs
@nl
type
label
Markus Krebs
@ast
Markus Krebs
@en
Markus Krebs
@es
Markus Krebs
@nl
prefLabel
Markus Krebs
@ast
Markus Krebs
@en
Markus Krebs
@es
Markus Krebs
@nl
P106
P31
P496
0000-0003-1625-2061